Growth Spurt Expected for TMC Life Sciences
Roy Quek, Executive Director, TMC Life Sciences
26-Jul-18 08:05
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
In March 2018, Singapore tycoon Peter Lim injected the privately-held Thomson Medical Group and TMC Life Sciences into the Singapore-listed real estate firm Rowsley. It was then renamed Thomson Medical Group -- to reflect its change in focus from real estate to healthcare. We speak to Roy Quek, Executive Director of TMC Life Sciences, on aligning the group’s plans with its parent company, as well as the healthcare issues driving private healthcare business in Malaysia.
Presented by: Melisa Idris
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Health Policy, Diseases and Conditions, Mental Health, Healthy Living, Fitness, Science, Business Analysis, Medical Innovation and Technology, Social Issues
Tags: Private Healthcare, Hospitals, TMC Life Sciences, Thomson Medical Group,
